Abstract:The cases of inflammatory bowel disease (IBD) are increasing rapidly around the world. Due to the multifactorial causes of IBD, there is an urgent need to understand the pathogenesis of IBD. As such, the usage of high-throughput techniques to profile genetic mutations, microbiome environments, transcriptome and proteome (e.g. lipidome) is increasing to understand the molecular changes associated with IBD, including two major etiologies of IBD: Crohn disease (CD) and ulcerative colitis (UC). In the case of transcriptome data, RNA sequencing (RNA-seq) technique is used frequently. However, only protein-coding genes are analyzed, leaving behind all other RNAs, including non-coding RNAs (ncRNAs) to be unexplored. Among these ncRNAs, long non-coding RNAs (lncRNAs) may hold keys to understand the pathogenesis of IBD as lncRNAs are expressed in a cell/tissue-specific manner and dysregulated in a disease, such as IBD. However, it is rare that RNA-seq data are analyzed for lncRNAs. To fill this gap in knowledge, we re-analyzed RNA-seq data of CD and UC patients compared with the healthy donors to dissect the expression profiles of lncRNA genes. As inflammation plays key roles in the pathogenesis of IBD, we conducted loss-of-function experiments to provide functional data of IBD-specific lncRNA, lung cancer associated transcript 1 (LUCAT1), in an in vitro model of macrophage polarization. To further facilitate the lncRNA research in IBD, we built a web database, IBDB (https://ibd-db.shinyapps.io/IBDB/), to provide a one-stop-shop for expression profiling of protein-coding and lncRNA genes in IBD patients compared with healthy donors.

Lnc-ing RNA to intestinal homeostasis and inflammation

Role of long non-coding RNA in inflammatory bowel disease

Profiling the Lncrna-Mirna-mrna Cerna Network to Reveal Potential Crosstalk Between Inflammatory Bowel Disease and Colorectal Cancer

The Role of Long Noncoding RNAs in Intestinal Health and Diseases: A Focus on the Intestinal Barrier

LncRNA: A Potential Research Direction in Intestinal Barrier Function

Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.

Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease

Emerging role of long noncoding RNAs as regulators of innate immune cell development and inflammatory gene expression

Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases

The role of long non-coding RNA in Crohn's disease

Non-coding RNAs as a Critical Player in the Regulation of Inflammasome in Inflammatory Bowel Diseases; Emphasize on lncRNAs

Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system

The role of lncRNAs in innate immunity and inflammation

The Role of lncRNAs in Regulating the Intestinal Mucosal Mechanical Barrier

Long Noncoding RNA: Genomics and Relevance to Physiology.

A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation

Systematic analysis and characterization of long non-coding RNA genes in inflammatory bowel disease

A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis

Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation

LncRNAs in adaptive immunity: role in physiological and pathological conditions

LncRNA XIST: A Breakthrough in Inflammation-related Diseases